These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 25244939)
1. Genomic instability causes HGF gene activation in colon cancer cells, promoting their resistance to necroptosis. Seneviratne D; Ma J; Tan X; Kwon YK; Muhammad E; Melhem M; DeFrances MC; Zarnegar R Gastroenterology; 2015 Jan; 148(1):181-191.e17. PubMed ID: 25244939 [TBL] [Abstract][Full Text] [Related]
2. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer. Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056 [TBL] [Abstract][Full Text] [Related]
3. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21. Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571 [TBL] [Abstract][Full Text] [Related]
4. Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome. Kammula US; Kuntz EJ; Francone TD; Zeng Z; Shia J; Landmann RG; Paty PB; Weiser MR Cancer Lett; 2007 Apr; 248(2):219-28. PubMed ID: 16945480 [TBL] [Abstract][Full Text] [Related]
5. Transcriptional upregulation of c-MET is associated with invasion and tumor budding in colorectal cancer. Bradley CA; Dunne PD; Bingham V; McQuaid S; Khawaja H; Craig S; James J; Moore WL; McArt DG; Lawler M; Dasgupta S; Johnston PG; Van Schaeybroeck S Oncotarget; 2016 Nov; 7(48):78932-78945. PubMed ID: 27793046 [TBL] [Abstract][Full Text] [Related]
6. Comparative characterization of the HGF/Met and MSP/Ron systems in primary pancreatic adenocarcinoma. Vanderwerff BR; Church KJ; Kawas LH; Harding JW Cytokine; 2019 Nov; 123():154762. PubMed ID: 31254927 [TBL] [Abstract][Full Text] [Related]
7. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms. Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720 [TBL] [Abstract][Full Text] [Related]
8. Transforming Growth Factor β Signaling in Colorectal Cancer Cells With Microsatellite Instability Despite Biallelic Mutations in TGFBR2. de Miranda NF; van Dinther M; van den Akker BE; van Wezel T; ten Dijke P; Morreau H Gastroenterology; 2015 Jun; 148(7):1427-37.e8. PubMed ID: 25736321 [TBL] [Abstract][Full Text] [Related]
9. Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia. Kentsis A; Reed C; Rice KL; Sanda T; Rodig SJ; Tholouli E; Christie A; Valk PJ; Delwel R; Ngo V; Kutok JL; Dahlberg SE; Moreau LA; Byers RJ; Christensen JG; Vande Woude G; Licht JD; Kung AL; Staudt LM; Look AT Nat Med; 2012 Jul; 18(7):1118-22. PubMed ID: 22683780 [TBL] [Abstract][Full Text] [Related]
10. Necroptosis Induced by Ad-HGF Activates Endogenous C-Kit+ Cardiac Stem Cells and Promotes Cardiomyocyte Proliferation and Angiogenesis in the Infarcted Aged Heart. Liu J; Wu P; Wang H; Wang Y; Du Y; Cheng W; Xu Z; Zhou N; Wang L; Yang Z Cell Physiol Biochem; 2016; 40(5):847-860. PubMed ID: 27941320 [TBL] [Abstract][Full Text] [Related]
11. Somatic mutation and functional polymorphism of a novel regulatory element in the HGF gene promoter causes its aberrant expression in human breast cancer. Ma J; DeFrances MC; Zou C; Johnson C; Ferrell R; Zarnegar R J Clin Invest; 2009 Mar; 119(3):478-91. PubMed ID: 19188684 [TBL] [Abstract][Full Text] [Related]
12. Constitutively active c-Met kinase in PC-3 cells is autocrine-independent and can be blocked by the Met kinase inhibitor BMS-777607. Dai Y; Siemann DW BMC Cancer; 2012 May; 12():198. PubMed ID: 22639908 [TBL] [Abstract][Full Text] [Related]
13. Expression of the hepatocyte growth factor and c-Met in colon cancer: correlation with clinicopathological features and overall survival. Liu Y; Li Q; Zhu L Tumori; 2012; 98(1):105-12. PubMed ID: 22495710 [TBL] [Abstract][Full Text] [Related]
14. The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance. Huang X; Gan G; Wang X; Xu T; Xie W Autophagy; 2019 Jul; 15(7):1258-1279. PubMed ID: 30786811 [TBL] [Abstract][Full Text] [Related]
15. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate. Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147 [TBL] [Abstract][Full Text] [Related]
16. Bromodomain and Extraterminal (BET) protein inhibition suppresses tumor progression and inhibits HGF-MET signaling through targeting cancer-associated fibroblasts in colorectal cancer. Wen D; Wang Y; Zhu Z; Huang Z; Cui L; Wu T; Liu CY Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165923. PubMed ID: 32800944 [TBL] [Abstract][Full Text] [Related]
17. HGF regulates VEGF expression via the c-Met receptor downstream pathways, PI3K/Akt, MAPK and STAT3, in CT26 murine cells. Matsumura A; Kubota T; Taiyoh H; Fujiwara H; Okamoto K; Ichikawa D; Shiozaki A; Komatsu S; Nakanishi M; Kuriu Y; Murayama Y; Ikoma H; Ochiai T; Kokuba Y; Nakamura T; Matsumoto K; Otsuji E Int J Oncol; 2013 Feb; 42(2):535-42. PubMed ID: 23233163 [TBL] [Abstract][Full Text] [Related]
18. Functional expression of HGF and its receptor in human colorectal cancer. Otte JM; Schmitz F; Kiehne K; Stechele HU; Banasiewicz T; Krokowicz P; Nakamura T; Fölsch UR; Herzig K Digestion; 2000; 61(4):237-46. PubMed ID: 10878450 [TBL] [Abstract][Full Text] [Related]
19. HGF rescues colorectal cancer cells from EGFR inhibition via MET activation. Liska D; Chen CT; Bachleitner-Hofmann T; Christensen JG; Weiser MR Clin Cancer Res; 2011 Feb; 17(3):472-82. PubMed ID: 21098338 [TBL] [Abstract][Full Text] [Related]
20. The potential therapeutic and prognostic impacts of the c-MET/HGF signaling pathway in colorectal cancer. Parizadeh SM; Jafarzadeh-Esfehani R; Fazilat-Panah D; Hassanian SM; Shahidsales S; Khazaei M; Parizadeh SMR; Ghayour-Mobarhan M; Ferns GA; Avan A IUBMB Life; 2019 Jul; 71(7):802-811. PubMed ID: 31116909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]